Editorial comment on: Is there a synergistic effect of topical oestrogens when administered with antimuscarinics in the treatment of symptomatic detrusor overactivity?
Porru
Daniele
D
D000287:Administration, Topical; D001559:Benzhydryl Compounds / Q000008:administration & dosage* / Q000494:pharmacology; D003408:Cresols / Q000008:administration & dosage* / Q000494:pharmacology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000008:administration & dosage* / Q000494:pharmacology; D005260:Female; D006801:Humans; D018727:Muscarinic Antagonists / Q000008:administration & dosage* / Q000494:pharmacology; D010665:Phenylpropanolamine / Q000008:administration & dosage* / Q000494:pharmacology; D000068737:Tolterodine Tartrate; D053201:Urinary Bladder, Overactive / Q000188:drug therapy*
D001559:Benzhydryl Compounds; D003408:Cresols; D004967:Estrogens; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate